Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.78% |
| 2 | Healthcare | 3.27% |
| 3 | Industrials | 2.02% |
| 4 | Financials | 2.02% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
STMP
1176
PUT
DELISTED
Stamps.com, Inc.
STMP
| $35.4M | 0.01% |
180,300
+45,600
| +34% | +$10M |
|
1177
PUT
Dominion Energy
D
$60.3B
| $35.3M | 0.01% |
470,000
-42,900
| -8% | -$3.41M |
|
1178
Ionis Pharmaceuticals
IONS
$9.32B
| $35.3M | 0.01% |
624,990
-1,344,523
| -68% | -$67M |
|
1179
TG Therapeutics
TGTX
$7.47B
| $35.3M | 0.01% |
678,766
+174,554
| +35% | +$5.9M |
|
1180
Nice
NICE
$6.05B
| $35.3M | 0.01% |
124,452
+26,014
| +26% | +$6.33M |
|
1181
PUT
CRISPR Therapeutics
CRSP
$5.15B
| $35.3M | 0.01% |
230,300
+149,400
| +185% | +$17.7M |
|
|
WPX
1182
DELISTED
WPX Energy, Inc.
WPX
| $35.2M | 0.01% |
4,323,736
+1,317,666
| +44% | +$8.37M |
|
1183
PUT
Kraft Heinz
KHC
$30B
| $35.2M | 0.01% |
1,015,000
-867,700
| -46% | -$28.2M |
|
|
AMED
1184
DELISTED
Amedisys
AMED
| $35.2M | 0.01% |
119,896
-72,171
| -38% | -$18.5M |
|
1185
PUT
Qorvo
QRVO
$8.69B
| $35.2M | 0.01% |
211,500
-24,000
| -10% | -$3.53M |
|
1186
Pan American Silver
PAAS
$20.4B
| $35.2M | 0.01% |
1,018,774
+287,579
| +39% | +$9.28M |
|
1187
PUT
Whirlpool
WHR
$2.76B
| $35.1M | 0.01% |
194,600
+19,500
| +11% | +$3.74M |
|
1188
PUT
Sarepta Therapeutics
SRPT
$1.88B
| $35.1M | 0.01% |
206,000
+17,100
| +9% | +$2.53M |
|
1189
CALL
Intercontinental Exchange
ICE
$86.4B
| $35M | 0.01% |
303,800
-22,500
| -7% | -$2.33M |
|
1190
Coca-Cola
KO
$378B
| $34.9M | 0.01% |
637,018
-1,136,027
| -64% | -$58.7M |
|
1191
CMS Energy
CMS
$22.2B
| $34.9M | 0.01% |
571,717
+114,066
| +25% | +$7.13M |
|
1192
PUT
Vanguard S&P 500 ETF
VOO
$1.04T
| $34.9M | 0.01% |
101,400
+15,500
| +18% | +$5.05M |
|
1193
Monolithic Power Systems
MPWR
$67.9B
| $34.8M | 0.01% |
+94,967
| New | +$30.4M |
|
1194
PUT
D.R. Horton
DHI
$41.7B
| $34.8M | 0.01% |
504,500
-215,700
| -30% | -$15.7M |
|
1195
PUT
Colgate-Palmolive
CL
$73.4B
| $34.6M | 0.01% |
405,200
-335,600
| -45% | -$27.8M |
|
1196
WEX
WEX
$6.68B
| $34.6M | 0.01% |
170,191
+97,777
| +135% | +$16.4M |
|
1197
PUT
Toll Brothers
TOL
$13.8B
| $34.6M | 0.01% |
796,500
+406,600
| +104% | +$18.9M |
|
1198
PUT
Agnico Eagle Mines
AEM
$94.9B
| $34.6M | 0.01% |
490,400
-237,700
| -33% | -$17.7M |
|
|
SPR
1199
CALL
DELISTED
Spirit AeroSystems
SPR
| $34.5M | 0.01% |
882,700
+429,700
| +95% | +$12.3M |
|
1200
Fortinet
FTNT
$118B
| $34.5M | 0.01% |
1,161,475
+936,955
| +417% | +$23.7M |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,989 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.